Testing Drugs Without the Animals
Regulators are finally letting AI predict drug safety before human trials, signaling a massive shift away from traditional animal testing.
June 19, 2026
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
FDA Accepts AI Model for Liver Toxicity
The regulatory bottleneck for AI in drug development is finally beginning to crack.
June 18, 2026
AI designs new antibiotic for drug-resistant infections
Generative AI just bypassed decades of traditional chemistry to design a viable antibiotic from scratch, but the real test lies in the clinical pipeline.
June 18, 2026
Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective.
Heterocyclic compounds drive pharmaceutical innovation, enhancing therapeutic agents and economic growth. Key insights from PubMed article. ππ
May 14, 2026
New Pediatric Brain Tumor Model Enhances Drug Testing
New pediatric brain tumor model improves drug testing. Developed by University of Trento and Bambino GesΓΉ Hospital. π§ π
May 14, 2026
Machine learning-driven discovery of therapeutic nucleoside hydrogels for periodontitis.
Machine learning identifies nucleoside hydrogels for periodontitis treatment, enhancing drug delivery and tissue engineering. π¦·π§
May 12, 2026
AI Tools Developed to Enhance Drug Development Process
AI tools like YuelDesign, YuelPocket, and YuelBond aim to speed up drug development processes. ππ€
May 10, 2026
Target identification and assessment in the era of AI.
AI revolutionizes drug target identification, enhancing success rates and efficiency in clinical trials. ππ
April 21, 2026
AI-Driven Protein Design Enhances Development of Intracellular Antibodies
AI-driven protein design improves the creation of stable intracellular antibodies, aiding diagnostics and biomedical research. π§¬π¬
April 10, 2026
Blueprint for Drug Repurposing Success: Foundational Concepts and Practical Framework.
Exploring drug repurposing: faster approvals, AI integration, and innovative strategies. π§¬π
March 30, 2026